TOSI, FEDERICA MARIA
 Distribuzione geografica
Continente #
EU - Europa 3.420
AS - Asia 2.362
NA - Nord America 2.022
SA - Sud America 253
AF - Africa 75
OC - Oceania 31
Totale 8.163
Nazione #
US - Stati Uniti d'America 1.891
DE - Germania 1.109
CN - Cina 905
IT - Italia 612
CH - Svizzera 473
SG - Singapore 465
GB - Regno Unito 263
VN - Vietnam 195
BR - Brasile 177
HK - Hong Kong 152
JP - Giappone 140
ES - Italia 130
IN - India 124
FR - Francia 121
SE - Svezia 115
RU - Federazione Russa 110
BD - Bangladesh 101
FI - Finlandia 99
CA - Canada 85
NL - Olanda 78
IE - Irlanda 64
DK - Danimarca 55
ID - Indonesia 45
TR - Turchia 36
MX - Messico 35
KR - Corea 33
PT - Portogallo 28
TW - Taiwan 28
AU - Australia 27
PL - Polonia 26
RO - Romania 25
AR - Argentina 23
AT - Austria 23
BE - Belgio 22
CI - Costa d'Avorio 21
IL - Israele 18
CO - Colombia 17
IQ - Iraq 15
PH - Filippine 15
GR - Grecia 13
CL - Cile 12
EC - Ecuador 12
ZA - Sudafrica 12
IR - Iran 10
PK - Pakistan 10
UA - Ucraina 10
EG - Egitto 9
NO - Norvegia 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
JO - Giordania 8
MA - Marocco 8
UZ - Uzbekistan 8
MY - Malesia 7
SC - Seychelles 7
TH - Thailandia 7
CY - Cipro 6
GN - Guinea 6
HU - Ungheria 5
SI - Slovenia 5
GE - Georgia 4
HR - Croazia 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PY - Paraguay 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
LT - Lituania 3
TN - Tunisia 3
AM - Armenia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GY - Guiana 2
KE - Kenya 2
LB - Libano 2
LU - Lussemburgo 2
SD - Sudan 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
LK - Sri Lanka 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 8.162
Città #
Frankfurt am Main 969
Zurich 453
Ashburn 261
Singapore 248
Milan 192
Southend 171
Beijing 133
Hong Kong 123
Chandler 115
San Jose 106
Redwood City 98
Dallas 88
Helsinki 76
Council Bluffs 73
New York 64
Ho Chi Minh City 62
Dublin 59
Fairfield 59
Los Angeles 58
Hefei 53
Guangzhou 49
Hanoi 45
Houston 44
Rome 44
Nanjing 41
Santa Clara 41
Wilmington 41
Dearborn 38
Tokyo 38
Shanghai 37
Jakarta 34
Princeton 34
Phoenix 30
Bengaluru 27
Lauterbourg 27
Buffalo 25
Madrid 25
Moscow 25
Woodbridge 25
Cambridge 24
Hangzhou 22
Jinan 22
Ottawa 22
Abidjan 21
Barcelona 20
Haiphong 19
São Paulo 19
Istanbul 18
Chicago 17
Munich 17
Shenyang 16
Toronto 16
Turin 16
Ann Arbor 15
Chengdu 15
Da Nang 15
Amsterdam 14
Changsha 14
Hyderabad 14
Wuhan 14
Seattle 13
Tianjin 13
Uppsala 13
Chennai 12
Des Moines 12
Fuzhou 12
Taipei 12
Atlanta 11
Boardman 11
Montreal 11
Schiffdorf 11
Vienna 11
Zhengzhou 11
Bologna 10
Lappeenranta 10
The Dalles 10
Berlin 9
Biên Hòa 9
Cairo 9
Central District 9
Hebei 9
London 9
Naples 9
Redmond 9
San Diego 9
Seoul 9
Sydney 9
Baghdad 8
Bucharest 8
Columbus 8
Modena 8
Mumbai 8
Orem 8
Warsaw 8
Amman 7
Bordeaux 7
Boston 7
Brussels 7
Charlotte 7
Chongqing 7
Totale 4.881
Nome #
Liquid biopsy for rectal cancer: a systematic review 1.711
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy 853
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches 595
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib 333
Strategies to tackle RAS-mutated metastatic colorectal cancer 290
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer 278
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 269
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA 252
The quest for improving treatment of cancer of unknown primary (CUP) through molecularly-driven treatments: a systematic review 250
Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review 246
Circulating tumor DNA to drive treatment in metastatic colorectal cancer 234
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature 222
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study 221
TRKA expression and NTRK1 gene copy number across solid tumours 221
Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients 214
The evolutionary landscape of treatment for BRAFv600e mutant metastatic colorectal cancer 209
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies 198
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers 196
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer 191
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study 190
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids 186
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer 178
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives 153
Immunocytokines in cancer treatment: A systematic review 143
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer 142
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection : a Systematic Review and Meta-Analysis 114
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 101
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors 99
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management 88
Totale 8.377
Categoria #
all - tutte 18.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 0 0 0 0 0 69 55
2021/2022797 76 63 63 99 93 52 75 52 74 35 38 77
2022/2023717 64 61 60 59 55 103 47 46 106 12 49 55
2023/20241.259 52 52 74 61 100 58 140 143 84 157 170 168
2024/20251.366 158 155 125 152 75 64 63 96 84 110 94 190
2025/20262.809 236 192 452 394 211 130 387 107 209 196 295 0
Totale 8.377